C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2007
12/27/2007	WO2007150020A1 Targeted immune conjugates
12/27/2007	WO2007149932A2 Methods and compositions for targeting hepsin
12/27/2007	WO2007149814A1 Methods of modulating il-22 and il-17
12/27/2007	WO2007149032A1 Antibody molecules for human il-17
12/27/2007	WO2007148417A1 Tumor-targeting monoclonal antibodies to fzd10 and uses thereof
12/27/2007	WO2007148063A1 Cd24-like protein
12/27/2007	WO2007147975A2 Antigenic surface structure of sperm cells associated with the y chromosome
12/27/2007	WO2007147901A1 Production of bispecific antibodies
12/27/2007	WO2007147823A1 Method for the preparation of specific antibodies against saccharidic antigens
12/27/2007	WO2007147623A2 A novel target in the treatment of cytokine release syndrome
12/27/2007	WO2007147265A1 Polynucleotides and polypeptide sequences involved in cancer
12/27/2007	WO2007109118A9 RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS
12/27/2007	WO2007095644A3 Reagents and methods for cancer prognosis and pathological staging
12/27/2007	WO2007084599A3 Methods of increasing lymphatic function
12/27/2007	WO2007082379A3 Method to identify cd40-sensitive cells using gene expression
12/27/2007	WO2005069859A3 Compositions and methods for modulating dhr96
12/27/2007	WO2005044200A3 Methods and compositions for treating mcp-1 related pathologies
12/27/2007	WO2005019267A8 Tie1-binding ligands
12/27/2007	US20070299247 Heterodimeric human cytokine receptor comprising interleukin-10 or orphan receptor components for use in treatment of cell proliferative, inflammatory and immune disorders
12/27/2007	US20070299244 Liposome allowing liposome-entrapped substance to escape from endosome
12/27/2007	US20070299016 Specific Antibodies for Diagnosing Heart Failure
12/27/2007	US20070298517 Immunoglobulin Peptides Against Heated Bovine Blood
12/27/2007	US20070298493 Transgenic animal cells containing endotheilial growth factor polypeptide for use as model system for treatment of cardiovascular and respiratory system disorders
12/27/2007	US20070298491 Human Secreted Proteins
12/27/2007	US20070298466 Method For The Construction Of Randomized Gene Sequence Libraries In Cells
12/27/2007	US20070298462 Process for Obtaining Antibodies
12/27/2007	US20070298460 Novel receptor that causes cell death
12/27/2007	US20070298459 Death Domain Containing Receptor 6; severe combined immunodeficiency (SCID); adenosine deaminase deficiency, agammaglobulinemia Bruton's disease
12/27/2007	US20070298445 Cancer Therapeutic
12/27/2007	US20070298443 Screening Method Using Antibody Heavy Chains
12/27/2007	US20070298412 Fluorescent Proteins And Chromoproteins From Non-Aequorea Hydrozoa Species And Methods For Using Same
12/27/2007	US20070298044 Enhancing the efficacy of immunotherapies by supplementing with complement
12/27/2007	US20070298042 Comprises two heavy chains and two light chains, each chain comprising a variable region and a constant region; vaccines for prevention and diagnosis of viral diseases
12/27/2007	US20070298041 Ligands That Enhance Endogenous Compounds
12/27/2007	US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
12/27/2007	US20070298036 PRO71238 Polypeptides
12/27/2007	US20070298035 Recombinant immunoglobulin for targeting, treatment and prevention of cancer, transplant rejection and viral infection
12/27/2007	US20070298034 Sulfotyrosine specific antibodies and uses therefor
12/27/2007	US20070298033 Human Anti-Idiotypic Antibody Fragments that Mimic Her-2/Neu
12/27/2007	US20070298032 Proteins Involved In Quorum Sensing
12/27/2007	CA2826738A1 Polynucleotides and polypeptide sequences involved in cancer
12/27/2007	CA2690973A1 Targeted immune conjugates
12/27/2007	CA2656168A1 Methods and compositions for targeting hepsin
12/27/2007	CA2655986A1 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator
12/27/2007	CA2655976A1 Antibody molecules for human il-17
12/27/2007	CA2655946A1 Antigenic surface structure of sperm cells associated with the y chromosome
12/27/2007	CA2655933A1 Polynucleotides and polypeptide sequences involved in cancer
12/27/2007	CA2655289A1 Tumor-targeting monoclonal antibodies to fzd10 and uses thereof
12/27/2007	CA2652924A1 Methods of modulating il-22 and il-17
12/26/2007	EP1870467A1 Polypeptide hormone Phosphatonin
12/26/2007	EP1870466A2 Compositions and methods for therapy and diagnosis of prostate cancer
12/26/2007	EP1870465A2 Chemokine receptors 88-2B (CKR-3) and 88C and their antibodies
12/26/2007	EP1870464A2 Methods and compositions for inhibiting neoplastic cell growth
12/26/2007	EP1870459A1 Methods for producing polypeptides by regulating polypeptide association
12/26/2007	EP1870458A1 sc(Fv)2 STRUCTURAL ISOMERS
12/26/2007	EP1870423A1 Y chromosom related to surface antigen on spermatic cells
12/26/2007	EP1870422A1 Means for the treatment of diseases characterized by an excessive immune reaction
12/26/2007	EP1870421A1 Novel anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate
12/26/2007	EP1869462A2 Biomarkers for ovarian cancer and endometrial cancer: hepcidin
12/26/2007	EP1869208A1 Anti-egfr antibody therapy based on an increased copy number of the egfr gene in tumor tissues
12/26/2007	EP1869192A2 Framework-shuffling of antibodies
12/26/2007	EP1869087A2 Antibodies against ccr5 and uses thereof
12/26/2007	EP1869086A1 Methods and compositions for modulating and detecting wisp activity
12/26/2007	EP1869085A2 Novel anti-plgf antibody
12/26/2007	EP1869084A2 Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues
12/26/2007	EP1869083A1 Assay method for group transfer reactions
12/26/2007	EP1868656A1 Bioactive stents for type ii diabetics and methods for use thereof
12/26/2007	EP1868651A2 Method of inducing neutralizing antibodies to human immunodeficiency virus
12/26/2007	EP1868650A2 Covalent diabodies and uses thereof
12/26/2007	EP1868648A2 Methods and compositions for modulating hyperstabilized c-met
12/26/2007	EP1868647A2 Antibodies that bind ov064 and methods of use therefor
12/26/2007	EP1868646A2 Composition comprising an antibody against macrophage colony-stimulating factor (m-csf) and a chelating agent
12/26/2007	EP1868644A1 Therapy of prostate cancer with ctla4 antibodies and hormonal therapy
12/26/2007	EP1427744B1 A system for antibody expression and assembly
12/26/2007	EP1409518B1 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis
12/26/2007	EP1401869B1 Molecules and methods for inhibiting shedding of kim-1
12/26/2007	EP1287024B1 Virulence genes, proteins, and their use
12/26/2007	EP1265914B1 Wnt-1 related polypeptides, and nucleic acids encoding the same
12/26/2007	EP1187634B1 Cell growth inhibition
12/26/2007	EP1116029B1 Apoptosis marker antibodies and methods of use
12/26/2007	EP0877812B1 Antibodies and immunoglobulin fusion proteins having modified effector functions and uses therefor
12/26/2007	EP0778848B1 Agents for inducing apoptosis and applications of said agents in therapy
12/26/2007	CN101095053A Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84
12/26/2007	CN101094869A Hk1-binding proteins
12/26/2007	CN101094868A Humanized anti-beta7 antagonists and uses therefor
12/26/2007	CN101094857A Cytotoxic agents comprising new taxanes
12/26/2007	CN101094841A Indinavir derivatives useful in immunoassay
12/26/2007	CN101092457A Human source Fab antibody for anti recombined alkalescent fibroblast growth factor and application
12/26/2007	CN101092456A Gene engineering antibody of human source neutrality for anti virus H5N1 of bird flu
12/26/2007	CN101092453A Therapeutic compounds comprised of anti-fc receptor binding agents
12/26/2007	CN101091795A Prevention and treatment of synucleinopathic disease
12/26/2007	CN100357430C 纤维蛋白溶解活性多肽 Polypeptide fibrinolytic activity
12/26/2007	CN100357325C Preparation method of anti apoA1, apoB antibody and reagent box used for detecting apoAI, apoB
12/26/2007	CN100357320C ZIBC gene and its coded protein and uses
12/25/2007	US7312374 Production of a transgenic avian by cytoplasmic injection
12/25/2007	US7312373 Nonhuman model animal lacking the ability to control lymphocyte migration
12/25/2007	US7312321 Antibody to human enzymes of the metalloprotease family
12/25/2007	US7312320 Neutralizing antibodies and methods of use thereof
12/25/2007	US7312319 Neurotrophic factor (NT-4) immunoassay systems
12/25/2007	US7312318 treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases

1 ... 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 ... 1494